Bibliography

Min J, Badesch D, Chakinala M, Elwing J, Frantz R, Horn E, Klinger J, Lammi M, Mazimba S, Sager J, et al. Prediction of Health-Related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR). American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 . Available from: https://www.atsjournals.org/doi/10.1164/rccm.202010-3967LE

Fakhri S, Hannon K, Moulden K, Peterson R, Hountras P, Bull T, Maloney J, De Marco T, Ivy D, Thenappan T, et al. Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry. Pulm Circ. 2020 ;10(4):2045894020964342.

Garry JD, Kolaitis NA, Kronmal R, Thenappan T, Hemnes A, Grinnan D, Bull T, Chakinala MM, Horn E, Simon MA, et al. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR). J Heart Lung Transplant. 2022 ;41(12):1808-1818.

Bernardo RJ, Lu D, Ramirez RL, Hedlin H, Kawut SM, Bull T, De Marco T, H Ford J, Grinnan D, Klinger JR, et al. Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry. Ann Am Thorac Soc. 2022 .

Kolaitis NA, Singer JP, Bartolome S, Chakinala MM, Grinnan D, Hemnes AR, Heresi GA, Leary PJ, Shlobin OA, Ventetuolo CE, et al. The landscape of referrals for lung transplantation in pulmonary arterial hypertension: a report from the Pulmonary Hypertension Association Registry. The Journal of Heart and Lung Transplantation [Internet]. 2025 . Available from: https://www.sciencedirect.com/science/article/pii/S1053249825020558